Preoperative Smoking and Narcotic, Benzodiazepine, and Tramadol Use Are Risk Factors for Narcotic Use After Hip and Knee Arthroplasty
Overview
Affiliations
Background: The use of narcotics has been found to be a modifiable risk factor for success of arthroplasty. We sought to determine the risk factors leading to increased narcotic use after total hip arthroplasty and total knee arthroplasty.
Methods: A retrospective chart review was performed on new patients presenting to an orthopedic reconstructive-service clinic. New patients aged 18 years or older with osteoarthritis of the hip or knee who presented over a 1-year period and underwent total knee arthroplasty or total hip arthroplasty were included. The Arkansas prescription monitoring program was then used to determine recent narcotic and benzodiazepine prescriptions filled within 3 months of surgery, and this was converted into morphine milligram equivalents (MME).
Results: One hundred seventy-nine patients met the inclusion criteria. When compared with patients who did not take any preoperative opioids, narcotic- and tramadol-only users filled an average of 86% and 38% more MME, respectively. Benzodiazepine users required an average of 81% more MME postoperative than nonusers, and smokers required an average of 90% more MME postoperative than nonsmokers. Subjects with body mass index >40 kg/m had 82% higher average postoperative MME than subjects with body mass index <25 kg/m. Age and sex had no significant correlation with postoperative narcotic use.
Conclusion: This study suggests that a patient's preoperative narcotic, tramadol, benzodiazepine, and tobacco use are correlated to the amount of postoperative narcotic prescriptions filled in the 3 months following surgery. Predisposition to substance abuse may be a characteristic which leads to increased postoperative narcotic use.
Wally M, Thompson M, Odum S, Kazemi D, Hsu J, Seymour R Appl Clin Inform. 2023; 14(5):961-972.
PMID: 38057261 PMC: 10700149. DOI: 10.1055/s-0043-1776879.
Effect of smoking on the redox status of knee osteoarthritis: A preliminary study.
Fernandez-Torres J, Aztatzi-Aguilar O, Zamudio-Cuevas Y, Sierra-Vargas M, Martinez-Nava G, Montano-Armendariz N Exp Biol Med (Maywood). 2023; 248(20):1754-1767.
PMID: 37916410 PMC: 10792422. DOI: 10.1177/15353702231199072.
Ardon A, Baloach A, Matveev S, Colontonio M, Narciso P, Spaulding A Anaesthesiol Intensive Ther. 2023; 55(3):205-211.
PMID: 37728448 PMC: 10496098. DOI: 10.5114/ait.2023.130661.
Emara A, Klika A, Piuzzi N Ann Surg Open. 2023; 2(2):e061.
PMID: 37636557 PMC: 10455349. DOI: 10.1097/AS9.0000000000000061.
New Perspective for Drug-Drug Interaction in Perioperative Period.
Silva A, Costa B, Castro I, Mourao J, Vale N J Clin Med. 2023; 12(14).
PMID: 37510925 PMC: 10381519. DOI: 10.3390/jcm12144810.